Related references
Note: Only part of the references are listed.Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding
Pleun Beelen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Calculating the sample size required for developing a clinical prediction model
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Sample size for binary logistic prediction models: Beyond events per variable criteria
Maarten van Smeden et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2019)
Prognostic Factors for the Failure of Endometrial Ablation A Systematic Review and Meta-analysis
Pleun Beelen et al.
OBSTETRICS AND GYNECOLOGY (2019)
Non-contraceptive benefits of intrauterine levonorgestrel administration: why not?
Lorenzo Sabbioni et al.
GYNECOLOGICAL ENDOCRINOLOGY (2017)
Usual medical treatments or levonorgestrel-IUS for women with heavy menstrual bleeding: long-term randomised pragmatic trial in primary care
Joe Kai et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2016)
Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods
Luis Bahamondes et al.
HUMAN REPRODUCTION UPDATE (2015)
Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey
Ian S. Fraser et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2015)
Levonorgestrel Intrauterine System versus Medical Therapy for Menorrhagia
Janesh Gupta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial
Malou C. Herman et al.
BMC WOMENS HEALTH (2013)
Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma
Alka Kriplani et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2012)
FINANCIAL AND QUALITY-OF-LIFE BURDEN OF DYSFUNCTIONAL UTERINE BLEEDING AMONG WOMEN AGREEING TO OBTAIN SURGICAL TREATMENT
Kevin D. Frick et al.
WOMENS HEALTH ISSUES (2009)
Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
Eric T. de Jonge et al.
CONTRACEPTION (2007)
Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system
Marko Elovainio et al.
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE (2007)
Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) - A systematic enquiry and overview
Rajesh Varma et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2006)
Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia:: predictors of outcome
R Hurskainen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2004)
Share Paper
